KW-0761 IV administration

2 trials

Sponsors

St. Marianna University School of Medicine Hospital

Conditions

HTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)

Phase 1

Phase I&IIa trial of KW-0761 in patients with HAM

Active, not recruitingJPRN-UMIN000012655

St. Marianna University School of Medicine HospitalHTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)

Start: 2014-01-10Target: 33Updated: 2026-06-29

Phase 2

Long-term study of KW-0761 in patients with HAM

Active, not recruitingJPRN-UMIN000019942

St. Marianna University School of Medicine HospitalHTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)

Start: 2015-11-30Target: 19Updated: 2026-06-29

Related Papers

Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy

Brain2023-04-2410 citations

Mogamulizumab (Anti-CCR4) in HTLV-1–Associated Myelopathy

New England Journal of Medicine2018-02-07106 citations